A research team led by investigators from Brigham and Women’s Hospital has evaluated real-world evidence related to outcomes for COVID-19 patients who were treated with hydroxychloroquine or chloroquine analogues (with or without a macrolide). Investigators found no evidence that either drug regimen reduced the death rate among patients.
- “Magic sand” might help us understand the physics of granular matter
- One size doesn’t fit all when it comes to products for preventing HIV from anal sex
- Study reveals how egg cells get so big
- Survey identifies factors in reducing clinical research coordinator turnover
- New ‘split-drive’ system puts scientists in the (gene) driver seat